Health
WASHINGTON, D.C. – Yesterday, the nonpartisan Congressional Budget Office (CBO) released its analysis of a newly announced Biden-Harris program intended to paper over…
Read More (CBO Confirms: Biden-Harris Election Year Medicare Cost-Shifting Policy Will Cost Taxpayers Billions)WASHINGTON, D.C. – With the cost of chronic diseases overwhelming family budgets and federal health care spending, Americans need better…
Read More (Four Key Moments: Hearing on Chronic Disease Prevention and Treatment)As prepared for delivery. “Good afternoon. Thank you to the witnesses for being here today to discuss a crucial issue…
Read More (Health Subcommittee Chair Buchanan Opening Statement – Hearing on Chronic Disease Prevention and Treatment)WASHINGTON, D.C. – Americans living with chronic diseases will have access to expanded treatment options provided through their employer’s health care…
Read More (Bipartisan Majority in Congress Endorses Expanding Coverage Options for Chronic Disease Treatment and Prevention)“The Chronic Disease Flexible Coverage Act actually codifies a Trump Administration policy that will incentivize employers to offer coverage for…
Read More (Chairman Smith Opening Statement – Floor Debate on the Chronic Disease Flexible Coverage Act)WASHINGTON, D.C. – Today, House Ways and Means Committee Chairman Jason Smith (R-MO) joined House Budget Committee Chairman Jodey Arrington…
Read More (Bicameral Request for Budgetary Analysis of New Biden-Harris Medicare Cost-Shifting Policy)With Vice President Kamala Harris promising to impose the largest tax hike in history, the so-called “Inflation Reduction Act” (IRA)…
Read More (The IRA is the Foundation of a Democrat Agenda that Grows the Bureaucracy, Harms Patients, and Benefits the Wealthy, the Well-Connected, & China)Today, the Biden-Harris Administration announced ten medications that will be subject to the Democrats’ brand of Washington-knows-best price controls under…
Read More (As Democrats Celebrate New Drug Price-Setting Scheme, Americans Are Already Paying the Price in Higher Health Care Costs)Lawmakers are calling on the Government Accountability Office (GAO) to review the Medicare Part D Premium Stabilization Demonstration recently announced by…
Read More (Bicameral Leaders Call for Review of Cost-Shifting Drug Price Policy)WASHINGTON, D.C. – Americans aging into the Medicare program will maintain access to their anti-obesity medications (AOMs) under legislation approved with…
Read More (What They Are Saying: Ways and Means Leading the Charge on Expanding Seniors’ Access to Medical Innovation & Life-Saving Treatments)